HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danilo Ranieri Selected Research

Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)

10/2021Role of FGFR2c and Its PKCε Downstream Signaling in the Control of EMT and Autophagy in Pancreatic Ductal Adenocarcinoma Cells.
6/2021Expression of the E5 Oncoprotein of HPV16 Impacts on the Molecular Profiles of EMT-Related and Differentiation Genes in Ectocervical Low-Grade Lesions.
1/2021The aberrant expression in epithelial cells of the mesenchymal isoform of FGFR2 controls the negative crosstalk between EMT and autophagy.
1/2019The Aberrant Expression of the Mesenchymal Variant of FGFR2 in the Epithelial Context Inhibits Autophagy.
1/2018Expression of the FGFR2c mesenchymal splicing variant in human keratinocytes inhibits differentiation and promotes invasion.
1/2018Role of FGFR2b expression and signaling in keratinocyte differentiation: sequential involvement of PKCδ and PKCα.
2/2016Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danilo Ranieri Research Topics

Disease

5Neoplasms (Cancer)
10/2021 - 07/2015
4Carcinogenesis
10/2021 - 01/2018
2Infections
12/2019 - 02/2011
1Adenocarcinoma
10/2021
1Squamous Intraepithelial Lesions
06/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2021
1Actinic Keratosis
04/2021
1Osteoarthritis
01/2019
1Tendinopathy (Tendonitis)
02/2016
1Papillomavirus Infections
07/2015
1Hypoxia (Hypoxemia)
07/2014
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
07/2012
1Human Influenza (Influenza)
02/2011

Drug/Important Bio-Agent (IBA)

7Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
10/2021 - 02/2016
3Protein Isoforms (Isoforms)IBA
01/2018 - 07/2015
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
04/2021
1Differentiation AntigensIBA
04/2021
1LipopolysaccharidesIBA
12/2019
1Peptides (Polypeptides)IBA
12/2019
1Interleukin-8 (Interleukin 8)IBA
12/2019
1Hyaluronic Acid (Hyaluronan)IBA
01/2019
1Viral ProteinsIBA
07/2015
1SugarsIBA
07/2014
1Ethanol (Ethyl Alcohol)IBA
07/2014
1Messenger RNA (mRNA)IBA
07/2012
1Viral HemagglutininsIBA
02/2011

Therapy/Procedure

2Extracorporeal Shockwave Therapy
01/2019 - 02/2016
1Intra-Articular Injections
01/2019